You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pediatric non-Hodgkin's Lymphoma high risk

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pediatric Anaplastic Large Cell Lymphoma Trial in Shanghai (P regimen, Course A1 + Vin, Course B1 +Vin)

Recruiting
  • Pediatric Anaplastic Large Cell Lymphoma
  • P regimen
  • +7 more
  • Shanghai, China
    Shanghai Children's Medical Center
Jul 23, 2022

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin Lymphoma Trial in Madison (TCRaß+/CD19+ depleted Haploidentical

Recruiting
  • Acute Myeloid Leukemia
  • +10 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Mar 1, 2022

Non-hodgkin Lymphoma, Hodgkin Lymphoma Trial in Valhalla (DOC Group B, Pv-COMRAD 1 and 2 Group B, Pv-R-CYM 1 and 2 Group B)

Recruiting
  • Non-hodgkin Lymphoma
  • Hodgkin Lymphoma
  • DOC Group B
  • +16 more
  • Valhalla, New York
    New York Medical College
Jun 9, 2022

Non-Hodgkin Lymphoma, Large B-cell Lymphoma Trial in Palo Alto (Axicabtagene Ciloleucel)

Not yet recruiting
  • Non-Hodgkin Lymphoma
  • Large B-cell Lymphoma
  • Axicabtagene Ciloleucel
  • Palo Alto, California
    Stanford University
Mar 20, 2023

Hodgkins Lymphoma, Non Hodgkins Lymphoma Trial in Houston (TAA-specific CTLs)

Recruiting
  • Hodgkins Lymphoma
  • Non Hodgkins Lymphoma
  • TAA-specific CTLs
  • Houston, Texas
    Texas Children's Hospital
Jul 14, 2022

Non-hodgkin Lymphoma, B Cell Trial in Switzerland (ctDNA detection)

Not yet recruiting
  • Non-hodgkin Lymphoma, B Cell
  • ctDNA detection
  • Aarau, Switzerland
  • +12 more
Oct 18, 2023

Acute Myeloid Leukemia, High Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, in Relapse Trial in Moscow (boost

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • boost anti-viral immunity after T-cell depleted HSCT
  • Moscow, Russian Federation
    Federal Research Center for pediatric hematology, oncology and i
Oct 1, 2021

NHL, Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis, Saint Louis (FT596, Rituximab)

Suspended
  • NHL
  • +3 more
  • Minneapolis, Minnesota
  • +1 more
Jan 31, 2023

Large B-cell Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Tampa (Comprehensive Ablative Bridging Irradiation (CABI),

Recruiting
  • Large B-cell Lymphoma
  • Relapsed Non-Hodgkin Lymphoma
  • Comprehensive Ablative Bridging Irradiation (CABI)
  • Chimeric Antigen Receptor T-Cell Therapy
  • Tampa, Florida
    Moffitt Cancer Center
Oct 26, 2023

Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Boston (CD79b-19 CAR T cells,

Not yet recruiting
  • Non-hodgkin Lymphoma
  • +9 more
  • CD79b-19 CAR T cells
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 6, 2023

Mature B-Cell Non-Hodgkin Lymphoma Trial (Obinutuzumab, Glofitamab, Rituximab)

Not yet recruiting
  • Mature B-Cell Non-Hodgkin Lymphoma
  • (no location specified)
Sep 6, 2022

Clinical, Laboratory and Epidemiologic Characterization of

Recruiting
  • Waldenstrom Macroglobulinemia
  • +4 more
    • Bethesda, Maryland
    • +1 more
    Jan 25, 2023

    DLBCL - Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma Trial (Bridging radiation therapy,

    Not yet recruiting
    • DLBCL - Diffuse Large B Cell Lymphoma
    • +6 more
    • Bridging radiation therapy
    • +2 more
    • (no location specified)
    Jan 4, 2023

    Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

    Active, not recruiting
    • Adult Grade III Lymphomatoid Granulomatosis
    • +23 more
    • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Jan 4, 2023

    Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +4 more
    • Utrecht, Netherlands
      Princess Máxima Center for Pediatric Oncology
    Feb 22, 2023

    Acute Lymphoblastic Leukemia, in Relapse, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Columbus

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +5 more
    • CD19 specific Chimeric Antigen Receptor T Cell
    • Columbus, Ohio
      Nationwide Children's Hospital
    Mar 9, 2023

    Hodgkin's Lymphoma Trial in Milan (histone deacetylase inhibitor (ITF2357))

    Terminated
    • Hodgkin's Lymphoma
    • histone deacetylase inhibitor (ITF2357)
    • Milan, Italy
      Istituto Nazionale per lo studio e la cura dei Tumori
    Jan 18, 2022

    Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +4 more
    • Utrecht, Netherlands
      Princess Máxima Center for Pediatric Oncology
    Feb 20, 2023

    Non-Hodgkin's Lymphoma Trial in New York (Etoposide, carboplatin, ifosfamide, Rituximab, Ifosfamide, Etoposide, Carboplatin,

    Completed
    Has Results
    • Non-Hodgkin's Lymphoma
    • Etoposide, carboplatin, ifosfamide
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    May 23, 2022

    Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +4 more
    • Utrecht, Netherlands
      Princess Máxima Center for Pediatric Oncology
    Feb 16, 2023

    High Grade B-Cell Non-Hodgkin's Lymphoma, Intermediate Grade B-Cell Non-Hodgkin's Lymphoma, Recurrent B-Cell Non-Hodgkin

    Not yet recruiting
    • High Grade B-Cell Non-Hodgkin's Lymphoma
    • +3 more
    • Anti-CD19-CAR CMV-specific T-lymphocytes
    • +9 more
    • Duarte, California
      City of Hope Medical Center
    Apr 5, 2023

    Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma

    Not yet recruiting
    • Lymphoma, B-Cell
    • +6 more
    • Plasma metabolomic profile by Ultra-high performance liquid chromatography with quadrupole time-of-flight mass spectrometry (UPLC-QTOFMS)
    • Guayaquil, Guayas, Ecuador
      Instituto Oncológico Nacional Dr. Juan Tanca Marengo
    Apr 27, 2023

    Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, MDS Trial in Tucson (Bendamustine, Cyclophosphamide)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +12 more
    • Tucson, Arizona
      The University of Arizona Cancer Center
    Dec 13, 2022

    MDS, de Novo, MDS, Secondary, MDS, Previously Treated Trial in Boston (Venetoclax, Azacitidine, Cytarabine)

    Recruiting
    • Myelodysplastic Syndromes, de Novo
    • +10 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Jan 23, 2023

    T-cell Lymphoblastic Lymphoma Trial in Shanghai, Chengdu (Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine,

    Not yet recruiting
    • T-cell Lymphoblastic Lymphoma
    • Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine, methotrexate, Dexamethasone, Doxorubicin
    • Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine, methotrexate, Dexamethasone, Doxorubicin, Vindesine, Etoposide, Ifosfamide
    • Shanghai, Shanghai, China
    • +1 more
    Dec 27, 2022